Hui Ju Chan

Consumer Services

Health Technology

Profile

Hui Ju Chan is currently the Chairman at PharmaDax (Guangzhou), Inc., Empax Pharma (Foshan) Inc., and Director at PharmaDax USA, Inc., Sandex Group Ltd., Fortune Tower Group Corp., and Shengqun Pharmaceutical Co., Ltd.
Additionally, Ms. Chan has been the President at PharmaDax Inc. since 2012.
Ms. Chan's education includes an undergraduate degree from National Taipei University of Technology and an MBA from Soochow University.

Hui Ju Chan active positions

Companies	Position	Start
PHARMADAX INC.	President	-
PharmaDax (Guangzhou), Inc.	Chairman	-
PharmaDax USA, Inc.	Director/Board Member	-
Sandex Group Ltd.	Director/Board Member	-
Fortune Tower Group Corp.	Director/Board Member	-
Empax Pharma (Foshan) Inc.	Chairman	-
Shengqun Pharmaceutical Co., Ltd.	Director/Board Member	-

All active positions of Hui Ju Chan

Training of Hui Ju Chan

National Taipei University of Technology	Undergraduate Degree
Soochow University /Taiwan/	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hui Ju Chan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
PharmaDax Inc. PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan.	Health Technology
PharmaDax USA, Inc.
PharmaDax (Guangzhou), Inc.
Sandex Group Ltd.
Fortune Tower Group Corp.
Empax Pharma (Foshan) Inc.
Shengqun Pharmaceutical Co., Ltd.

See company connections